chr17-7190812-T-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_001321075.3(DLG4):āc.2071A>Gā(p.Ile691Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,612,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001321075.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLG4 | NM_001321075.3 | c.2071A>G | p.Ile691Val | missense_variant, splice_region_variant | 20/20 | ENST00000399506.9 | NP_001308004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLG4 | ENST00000399506.9 | c.2071A>G | p.Ile691Val | missense_variant, splice_region_variant | 20/20 | 2 | NM_001321075.3 | ENSP00000382425 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151680Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461114Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726870
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151680Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74076
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.2200A>G (p.I734V) alteration is located in exon 22 (coding exon 22) of the DLG4 gene. This alteration results from a A to G substitution at nucleotide position 2200, causing the isoleucine (I) at amino acid position 734 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at